Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dabigatran (pradaxa) (1 trial)
enoxaparin (lovenox) (1 trial)
rivaroxaban (xarelto) (1 trial)
Trials (1 total)
Trial APIs (3 total)